We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$49.4B
AUM Growth
+$3.27B
Cap. Flow
+$4.69B
Cap. Flow %
9.5%
Top 10 Hldgs %
24.75%
Holding
2,665
New
250
Increased
1,263
Reduced
867
Closed
191

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$282M
2
AAPL icon
Apple
AAPL
+$280M
3
MSFT icon
Microsoft
MSFT
+$202M
4
AVGO icon
Broadcom
AVGO
+$201M
5
NVDA icon
NVIDIA
NVDA
+$193M

Sector Composition

Rank Sector Weight
1 Technology 15.74%
2 Financials 8.29%
3 Healthcare 7.21%
4 Consumer Staples 5.36%
5 Consumer Discretionary 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DC icon
2426
Dakota Gold
DC
$617M
$29.9K ﹤0.01%
11,297
+347
+3% +$952
CMPS
2427
Compass Pathways
CMPS
$1.47B
$29.4K ﹤0.01%
+10,287
New +$39.5K
AKTX
2428
Akari Therapeutics
AKTX
$14.4M
$29.3K ﹤0.01%
591
STEM icon
2429
Stem
STEM
$44.3M
$29K ﹤0.01%
+4,133
New +$47.9K
CHGG icon
2430
Chegg
CHGG
$116M
$28.9K ﹤0.01%
45,208
+31,366
+227% +$38.8K
BIVI icon
2431
BioVie
BIVI
$9.5M
$28.7K ﹤0.01%
2,933
+1,210
+70% +$19.3K
GERN icon
2432
Geron
GERN
$898M
$27.3K ﹤0.01%
17,176
-4,428
-20% -$10.8K
MSOS icon
2433
AdvisorShares Pure US Cannabis ETF
MSOS
$814M
$27.3K ﹤0.01%
10,454
PRLD icon
2434
Prelude Therapeutics
PRLD
$375M
$26.5K ﹤0.01%
34,565
+1,688
+5% +$1.57K
SID icon
2435
Companhia Siderúrgica Nacional
SID
$1.37B
$26.1K ﹤0.01%
15,623
-5,704
-27% -$8.77K
RXT icon
2436
Rackspace Technology
RXT
$960M
$25.7K ﹤0.01%
+15,235
New +$36.3K
SLRN
2437
DELISTED
ACELYRIN
SLRN
$25.7K ﹤0.01%
+10,419
New +$24.8K
OABI icon
2438
OmniAb
OABI
$283M
$25.7K ﹤0.01%
+10,693
New +$35K
STRO icon
2439
Sutro Biopharma
STRO
$386M
$25.4K ﹤0.01%
+3,907
New +$61.5K
ADCT icon
2440
ADC Therapeutics
ADCT
$140M
$25.3K ﹤0.01%
+17,912
New +$30.4K
BTBT icon
2441
Bit Digital
BTBT
$428M
$25K ﹤0.01%
+12,380
New +$35.7K
WTI icon
2442
W&T Offshore
WTI
$525M
$24K ﹤0.01%
15,515
+5,020
+48% +$8.28K
EVC icon
2443
Entravision Communication
EVC
$1.02B
$23.9K ﹤0.01%
11,382
-70
-0.6% -$153
LAB icon
2444
Standard BioTools
LAB
$342M
$23.8K ﹤0.01%
+22,031
New +$30.9K
IVVD icon
2445
Invivyd
IVVD
$160M
$23.8K ﹤0.01%
+39,293
New +$35.2K
FATE icon
2446
Fate Therapeutics
FATE
$275M
$23.6K ﹤0.01%
29,904
-793,230
-96% -$972K
RDW.WS
2447
DELISTED
Redwire Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
RDW.WS
$22K ﹤0.01%
37,069
MYPS icon
2448
PLAYSTUDIOS Inc
MYPS
$76.2M
$18.7K ﹤0.01%
+14,726
New +$24K
OLPX
2449
DELISTED
Olaplex Holdings
OLPX
$18.2K ﹤0.01%
14,355
+677
+5% +$1K
APLT
2450
DELISTED
Applied Therapeutics
APLT
$16.8K ﹤0.01%
+34,337
New +$20.2K

Similar funds

Cerity Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Cerity Partners held 2,665 positions worth $49.4B, up 7.1% from $46.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Cerity Partners deployed $4.69B of net new capital in Q1 2025, opening 250 new positions and adding to 1,263 existing holdings. Its largest new stake was Ezcorp Inc: 564,555 shares worth $8.31M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Tetra Tech, an estimated $26.9M trimmed.

  • Cerity Partners's largest Q1 2025 buy was Ezcorp Inc: 564,555 shares worth $8.31M.
  • Cerity Partners added most to Meta Platforms (Facebook) in Q1 2025, an estimated $282M increase.
  • Cerity Partners's biggest Q1 2025 reduction was Tetra Tech, cutting an estimated $26.9M.
  • Cerity Partners fully exited ExxonMobil in Q1 2025, selling an estimated $205M.
  • Cerity Partners's ten largest holdings make up 25% of its $49.4B portfolio in Q1 2025.
  • Cerity Partners opened 250 new positions and closed 191 in Q1 2025.
  • Cerity Partners's portfolio value rose 7.1% quarter-over-quarter to $49.4B.

Based on Cerity Partners's 13F filing for Q1 2025, filed 30 Apr 2025.